GtoPdb Ligand ID: 8967

Synonyms: clone III | Emgality® | galcanezumab-gnlm | LY-2951742 | LY2951742
galcanezumab is an approved drug (FDA (2018))
Compound class: Antibody
Comment: Galcanezumab (LY2951742) is a monoclonal antibody targeting calcitonin A and B (CALCA a.k.a. α-CGRP and CALCB a.k.a. β-CGRP respectively), whose anti-migraine and analgesic actions can be applied clinically.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent WO2007076336 [1].
Compound class Antibody
Approved drug? Yes (FDA (2018))
International Nonproprietary Names
INN number INN
10277 galcanezumab
clone III | Emgality® | galcanezumab-gnlm | LY-2951742 | LY2951742
Database Links
Specialist databases
IMGT/mAb-DB 609
Other databases
GtoPdb PubChem SID 310264747
Search PubMed clinical trials galcanezumab
Search PubMed titles galcanezumab
Search PubMed titles/abstracts galcanezumab